Galectin Therapeutics (GALT) Return on Capital Employed [ROCE] (2011 - 2026)
Galectin Therapeutics' Return on Capital Employed [ROCE] was -157.32% in Q1 2026, up 88.56 percentage points from the prior quarter.
Powered by 
Analysis
Galectin Therapeutics (GALT) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends
For FY2025, Return on Capital Employed [ROCE] at Galectin Therapeutics came in at -191.59%.
- Return on Capital Employed [ROCE] shows a five-year change of -121.88 percentage points (FY2020 to FY2025).
- In earlier years, Return on Capital Employed [ROCE] was -419.92% in FY2023 (-213.10 pp), -206.82% in FY2022 (-93.70 pp) and -113.11% in FY2021 (-43.41 pp).
- The Q1 2026 figure marks the highest quarterly Return on Capital Employed [ROCE] since Q1 2022.
- The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q4 2023 (a gain of 181.67 percentage points); the worst was Q2 2025 (a drop of 1572.95 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Galectin Therapeutics | 258.62 Mn | 258.62 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -157.32% |
| Dec 31, 2025 | -245.88% |
| Jun 30, 2025 | -1,899.27% |
| Sep 30, 2024 | -1,294.91% |
| Jun 30, 2024 | -326.32% |
| Mar 31, 2024 | -259.35% |
| Dec 31, 2023 | -400.53% |
| Sep 30, 2023 | -369.28% |
| Jun 30, 2023 | -373.53% |
| Mar 31, 2023 | -420.29% |
| Dec 31, 2022 | -582.19% |
| Sep 30, 2022 | -285.45% |
| Jun 30, 2022 | -187.00% |
| Mar 31, 2022 | -119.91% |
| Dec 31, 2021 | -97.67% |
| Sep 30, 2021 | -111.54% |
| Jun 30, 2021 | -127.93% |
| Mar 31, 2021 | -121.27% |
| Dec 31, 2020 | -88.72% |
| Sep 30, 2020 | -59.10% |
API Access
Galectin Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=GALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "GALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=GALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();